Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 23, 2024Cardiovascular ResearchOpen Access

Cardiac and perivascular myofibroblasts, matrifibrocytes, and immune fibrocytes in hypertension; commonalities and differences with other cardiovascular diseases

View Full Paper
Ask AI
Bookmark
Share

Key result

Distinct fibroblast populations including matrifibrocytes and immune fibrocytes mediate hypertension-related cardiovascular fibrosis.

Why the study?

Cardiovascular fibrosis contributes to vascular resistance, aortic stiffness, and cardiac hypertrophy in hypertension, but the molecular mechanisms leading to fibroblast activation remain largely unknown.

Design

Review

Authors

KTKeiichi TorimotoKEKatherine J. ElliottYNYuki Nakayama

Discussion

Loading...

Member takes

Overview

Supports targeting matrifibrocytes and immune fibrocytes in hypertension fibrosis research; hypothesis-generating and should not yet change practice.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Torimoto et al. (2024) studied this question. Distinct fibroblast populations, including matrifibrocytes and immune fibrocytes, play critical roles in cardiovascular fibrosis related to hypertension and other diseases.

synapsesocial.com/papers/69696f0bffe1ecee9edd5e77https://doi.org/10.1093/cvr/cvae044
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cardiac fibrosis2020 · 1,222 citations
  2. 2Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications2016 · 391 citations
  3. 3Targeting cardiac fibrosis with engineered T cells2019 · 834 citations
  4. 4CAR T cells produced in vivo to treat cardiac injury2022 · 1,355 citations
  5. 5Fibroblasts in the Infarcted, Remodeling, and Failing Heart2019 · 430 citations